-
公开(公告)号:EP2535053A4
公开(公告)日:2014-12-31
申请号:EP11739762
申请日:2011-02-02
Applicant: KAO CORP
Inventor: HARAMIZU SATOSHI , OTA NORIYASU , MURASE TAKATOSHI
CPC classification number: A23L2/52 , A23K20/158 , A23L33/10 , A23L33/115 , A61K35/20
-
公开(公告)号:EP2036551A4
公开(公告)日:2010-06-30
申请号:EP07737277
申请日:2007-06-12
Applicant: KAO CORP
Inventor: OTA NORIYASU , MURASE TAKATOSHI
IPC: A61K31/353 , A23L1/30 , A23L2/38 , A61P21/00
CPC classification number: A61K31/353 , A23L33/105 , A23P20/105 , A23V2002/00 , A23V2200/316 , A23V2250/2132
-
公开(公告)号:EP2409696A4
公开(公告)日:2016-04-20
申请号:EP10753295
申请日:2010-03-17
Applicant: KAO CORP
Inventor: MURASE TAKATOSHI , MISAWA KOICHI , MINEGISHI YOSHIHIKO , OTA NORIYASU , OHMINAMI HIDEO
IPC: A61K31/216 , A23F5/24 , A61P3/00 , A61P3/06 , A61P3/10
CPC classification number: A23L2/52 , A23K20/111 , A23K50/40 , A23L33/10 , A23L33/105 , A23L33/30 , A23V2002/00 , A61K31/216 , A23V2200/332 , A23V2250/028 , A23V2250/0644 , A23V2250/641 , A23V2250/7042 , A23V2250/7044 , A23V2250/7052
Abstract: Provision of a pharmaceutical product, a quasi-drug, a food, a beverage, a pet food, a feed, and others which are highly safe, have excellent action of promoting energy consumption, promoting fat burning, promoting carbohydrate burning, or improving an effect of exercise, and which are effective for the prevention or amelioration of obesity or metabolic syndrome or the improvement of motor functions. An agent for promoting energy consumption, an agent for promoting fat burning, an agent for promoting carbohydrate burning, an agent for improving an effect of exercise, an agent for improving motor functions, an agent for inhibiting acetyl-CoA carboxylase 2, and an agent for inhibiting pyruvate dehydrogenase kinase 4 containing chlorogenic acids or salts thereof as an active ingredient.
-
公开(公告)号:EP2617429A4
公开(公告)日:2014-02-19
申请号:EP11825208
申请日:2011-09-14
Applicant: KAO CORP
Inventor: SOGA SATOKO , OTA NORIYASU , SHIMOTOYODOME AKIRA , MURASE TAKATOSHI
CPC classification number: A61K31/216 , A23F5/185 , A23F5/24 , A23L33/105 , A23V2002/00 , A61K31/05 , A61K36/74 , A23V2200/332 , A23V2250/2108 , A61K2300/00
-
公开(公告)号:EP2774615A4
公开(公告)日:2016-02-17
申请号:EP12842024
申请日:2012-10-16
Applicant: KAO CORP
Inventor: HARAMIZU SATOSHI , MORI TAKUYA , OTA NORIYASU , SHIMOTOYODOME AKIRA
-
公开(公告)号:EP2532351A4
公开(公告)日:2013-06-12
申请号:EP11739761
申请日:2011-02-02
Applicant: KAO CORP
Inventor: HARAMIZU SATOSHI , OTA NORIYASU , HASHIZUME KOHJIRO , MURASE TAKATOSHI
IPC: A61K31/688 , A61P3/04 , A61P3/06 , A61P43/00
CPC classification number: A61K31/688 , A23L33/115
-
公开(公告)号:EP2036552A4
公开(公告)日:2009-11-04
申请号:EP07790236
申请日:2007-06-29
Applicant: KAO CORP
Inventor: OTA NORIYASU , HARAMIZU SATOSHI , MURASE TAKATOSHI
IPC: A61K31/353 , A23L1/30 , A61K36/00 , A61K36/82 , A61P43/00
CPC classification number: A61K36/752 , A23L2/52 , A23L33/105 , A23L33/175 , A23V2002/00 , A61K31/353 , A23V2200/302 , A23V2250/06 , A23V2250/2116 , A23V2200/316
Abstract: Provision of a drug, a quasi-drug, and a food or beverage, which are effective for senescence inhibition, mitochondrial function improvement, muscle dysfunction inhibition, muscular atrophy inhibition, prevention of a bedridden state, muscle senescence inhibition, or motor function improvement. A senescence inhibitor, a mitochondrial function-improving agent, a muscle dysfunction inhibitor, a muscular atrophy inhibitor, and an agent for preventing a bedridden state, containing a catechin as an effective ingredient. A muscle senescence inhibitor and a motor function-improving agent, containing a catechin and an amino acid as effective ingredients.
-
-
-
-
-
-